Meet Your Team
Internationally Recognized
Experts
Meet Your Team
Internationally
Recognized
Experts

Your Cancer Care Team

SCRI Oncology Partners is committed to bringing clinical trials and pioneering therapies directly to you. As a cancer treatment center led by globally recognized oncologists with specialized expertise in cancer care, we provide comprehensive, cutting-edge care that is accessible and ready for you when you need it most.

More Filters

Our experienced team

Deepak Bhamidipati, MD
Gastrointestinal cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Benjamin Garmezy, MD
Genitourinary cancers, including prostate, kidney, bladder and testicular, Clinical trials and research advancements, Early-phase drug development
Nashville, Tennessee 37203
Erika Hamilton, MD
Breast cancer, Clinical trials and research advancements, Cancers related to women’s health, Early-phase drug development
Nashville, Tennessee 37203
Melissa Johnson, MD
Lung cancer, Clinical trials and research advancements, Early-phase drug development
Nashville, Tennessee 37203
Meredith McKean, MD, MPH
Melanoma, Skin cancer, Clinical trials and research advancements, Early-phase drug development
Nashville, Tennessee 37203
Krish Patel MD
Lymphoma, Chronic Lymphocytic Leukemia, Immunotherapy, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Meredith Pelster, MD, MSCI
Gastrointestinal cancers, Head and neck cancers, Clinical trials and research advancement, Early-phase drug development
Nashville, Tennessee 37203
David Spigel, MD
Lung cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Vivek Subbiah, MD
Endocrine cancer, Precision oncology, Sarcoma cancer, Targeted therapy and immunotherapy, Clinical trials and research advancements
Nashville, Tennessee 37203
Denise Yardley, MD
Breast cancer, Benign-hematology, Clinical trials and research advancements
Nashville, Tennessee 37203
Deepak Bhamidipati, MD
Nashville, Tennessee 37203
Gastrointestinal cancer, Early-phase drug development, Clinical research
Benjamin Garmezy, MD
Nashville, Tennessee 37203
Genitourinary cancers, including prostate, kidney, bladder and testicular, Clinical trials and research advancements, Early-phase drug development
Erika Hamilton, MD
Nashville, Tennessee 37203
Breast cancer, Clinical trials and research advancements, Cancers related to women’s health, Early-phase drug development
Melissa Johnson, MD
Nashville, Tennessee 37203
Lung cancer, Clinical trials and research advancements, Early-phase drug development
Meredith McKean, MD, MPH
Nashville, Tennessee 37203
Melanoma, Skin cancer, Clinical trials and research advancements, Early-phase drug development
Krish Patel MD
Nashville, Tennessee 37203
Lymphoma, Chronic Lymphocytic Leukemia, Immunotherapy, Early-phase drug development, Clinical research
Meredith Pelster, MD, MSCI
Nashville, Tennessee 37203
Gastrointestinal cancers, Head and neck cancers, Clinical trials and research advancement, Early-phase drug development
David Spigel, MD
Nashville, Tennessee 37203
Lung cancer, Early-phase drug development, Clinical research
Vivek Subbiah, MD
Nashville, Tennessee 37203
Endocrine cancer, Precision oncology, Sarcoma cancer, Targeted therapy and immunotherapy, Clinical trials and research advancements
Denise Yardley, MD
Nashville, Tennessee 37203
Breast cancer, Benign-hematology, Clinical trials and research advancements

Advance practice providers

Gretchen Drake, FNP-C, AOCNP
Early phase drug development of all solid tumor types, Clinical research
Nashville, Tennessee 37203
Katie Estopinal, MSN, AG-ACNP-BC, AOCNP
Early-phase drug development, Genitourinary oncology
Nashville, Tennessee 37203
Sharon Hale, ACNP
Breast cancer, Lung cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Kayla Hobbs, FNP-BC
Gastrointestinal cancer, Head and neck cancers, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Melissa Kincade, MS, FNP-C
Gastrointestinal cancer, Head and neck cancers, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Alexis Lee, FNP-BC
Lung cancer, Head and neck cancers, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Kelsey Martin, APRN, AOCNP
Breast cancer, Gynecologic cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Tricia Morris, ANP-BC, AOCNP
Breast cancer, Benign hematology, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Sarah Purcell, NP
Palliative care, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Melissa Rikal, FNP-BC, AOCNP
Breast cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Erin Shoates, FNP-BC, AOCNP
Melanoma and other skin cancers, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
What is a cancer care team?

A cancer care team is a group of specialized healthcare professionals who work together to provide comprehensive care before, during, and after cancer treatment. This team typically includes a variety of experts, each bringing a unique set of skills and expertise to address different aspects of cancer care. 

Key members of a cancer care team often include medical oncologists, surgical oncologists, radiation oncologists, and in some cases, interventional radiologists. These doctors lead your treatment, coordinating with other healthcare providers to ensure a cohesive approach.  

Nurses and nurse practitioners also play crucial roles. Our nurse practitioners are specially trained in oncologyThey not only provide medical care, but also offer support, answer questions, and help you navigate the emotional and practical aspects of your diagnosis. 

In addition to doctors and nurses, your care team may include other professionals such as social workers, pharmacists, dietitians, palliative care providers, and specialists who focus on particular types of cancer, treatments, or health issues related to cancer. These team members may work directly with your core cancer care team within the same facility or be referred from other locations to address specific needs. This collaborative approach ensures that you receive well-rounded care tailored to your individual situation. 

What cancers does SCRI Oncology Partners treat?
  • Breast
  • Central Nervous System
  • Gastrointestinal (Colon, Rectal, Esophageal, Gastric, Liver, Biliary, Pancreatic)
  • Genitourinary (Bladder, Kidney, Prostate, Testicular/Germ Cell)
  • Gynecologic (Ovarian, Fallopian, Uterine, Cervical, Vulvar)
  • Head and Neck
  • Lung (Non-Small-Cell, Small-Cell, Mesothelioma)
  • Melanoma (Uveal, Cutaneous, Mucosal) Basal Cell, Squamous
  • Neuroendocrine and Adrenal
  • Sarcoma
  • Unknown Primary
How can I find access to the latest cancer treatments?

To access the latest cancer treatments, one of the most common and preferred methods is through participation in a clinical trial. Clinical trials are research studies designed to evaluate new drugs and treatments, and they offer participants the opportunity to receive cutting-edge therapies ahead of when these drugs would be commercially available to all.  

If you’re considering a clinical trial as a treatment option, the best place to start is by discussing it with your doctor or another member of your healthcare team. Your doctor may already be aware of a clinical trial that could be suitable for you, or they can help search for one, provide detailed information, and answer any questions you may have about joining. 

It‘s beneficial to work with a cancer care team like SCRI Oncology Partners. We specialize in providing second opinions on treatment options, including opportunities to participate in clinical trials. SCRI Oncology Partners is dedicated to bringing clinical trials and groundbreaking therapies to local communities, offering state-of-the-art, personalized care led by globally recognized oncologists with expertise in cancer care and clinical research.

Recent Articles

Six Must-Knows about Bladder Cancer

Six Must-Knows about Bladder Cancer

Bladder cancer is the fourth most common cancer diagnosed in men, and men are four times more likely than women to develop it.

What is Metastatic Breast Cancer?

What is Metastatic Breast Cancer?

Metastatic breast cancer is breast cancer that has spread from the breast to other parts of the body. This is also referred to as advanced or stage 4 breast cancer.

Contact Us

Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.

Contact Us

Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.

Contact us

Contact Us

Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.

Contact us